Adagio Medical Holdings, Inc. Receives Nasdaq Non-Compliance Notice for Minimum Bid Price

Adagio Medical Holdings, Inc. was notified by Nasdaq on June 12, 2026, that its common stock is not in compliance with the $1.00 minimum bid price rule, having been below this threshold for 30 consecutive business days. The company has 180 days, until December 9, 2026, to regain compliance by ensuring its stock price closes at or above $1.00 for ten consecutive trading days. During this period, the stock will continue trading on the Nasdaq Capital Market. Adagio Medical Holdings is exploring options to meet the requirement, including a potential reverse stock split, and may be eligible for a second 180-day compliance period if necessary. Failure to comply by the deadline could result in delisting.